Randomized Controlled Trial
Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer.
Int. J. Radiat. Oncol. Biol. Phys. 2012 Mar 15; 82 (4): 1367-75.
Multicenter Study
Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: a phase II trial.
Eur. J. Cancer. 2012 Jan 1; 48 (1): 37-45.
Randomized Controlled Trial
Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer.
Radiat Oncol. 2010 Jan 1; 5: 88.